Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans

Kidney International

Volumn 80, Issue 12, 2011, Pages 1339-1343

  Hicks, Pamela J ^a   Langefeld, Carl D ^a   Lu, Lingyi ^a   Bleyer, Anthony J ^a   Divers, Jasmin ^a   Nachman, Patrick H ^b   Derebail, Vimal K ^b   Bowden, Donald W ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

African American; APOL1; diabetes; end stage kidney disease; hemoglobin S; hypertension

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; HEMOGLOBIN S; MYOSIN HEAVY CHAIN; NON MYOSIN HEAVY CHAIN 9; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SICKLE CELL TRAIT;

EID: 82455164204     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.286     Document Type: Article

References (21)

1. Prabhakar H, Haywood Jr C, Molokie R. Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival. Am J Hematol 2010; 85: 346-353.
2. Buckalew Jr VM, Someren A. Renal manifestations of sickle cell disease. Arch Intern Med 1974; 133: 660-669.
3. Tsaras G, Owusu-Ansah A, Boateng FO et al. Complications associated with sickle cell trait: a brief narrative review. Am J Med 2009; 122: 507-512.
4. Ajayi AA, Kolawole BA. Sickle cell trait and gender influence type 2 diabetic complications in African patients. Eur J Intern Med 2004; 15: 312-315.
5. Bleyer AJ, Vidya S, Sujata L et al. Sickle cell trait and development of microvascular complications in diabetes mellitus. Clin J Am Soc Nephrol 2010; 5: 1015-1020.
6. Oli JM, Watkins PJ, Wild B et al. Albuminuria in Afro-Caribbeans with Type 2 diabetes mellitus: is the sickle cell trait a risk factor? Diabet Med 2004; 21: 483-486.
7. Derebail VK, Nachman PH, Key NS et al. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol 2010; 21: 413-417.
8. Heller P, Best WR, Nelson RB et al. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979; 300: 1001-1005.
9. Schneider RG, Hightower B, Hosty TS et al. Abnormal hemoglobins in a quarter million people. Blood 1976; 48: 629-637.
10. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
11. Freedman BI, Kopp JB, Langefeld CD et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010; 21: 1422-1426.
12. Kopp JB, Smith MW, Nelson GW et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40: 1175-1184.
13. Kao WH, Klag MJ, Meoni LA et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40: 1185-1192.
14. Freedman BI, Hicks PJ, Bostrom MA et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 2009; 75: 736-745.
15. Bostrom MA, Freedman BI. The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol 2010; 5: 1107-1113.
16. Meyer LM, Adams III JG, Steinberg MH et al. Screening for sickle cell trait: the Veterans Administration National Sickle Cell Program. Am J Hematol 1987; 24: 429-432.
17. McDonough CW, Palmer ND, Hicks PJ et al. A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 2011; 79: 563-572.
18. Bowden DW, Colicigno CJ, Langefeld CD et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int 2004; 66: 1517-1526.
19. Divers J, Register TC, Langefeld CD et al. Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res 2011; 26: 1554-1560.
20. Keene KL, Mychaleckyj JC, Leak TS et al. Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet 2008; 124: 147-154.
21. Yang Q, Khoury MJ, Sun F et al. Case-only design to measure gene-gene interaction. Epidemiology 1999; 10: 167-170.